BR9811499A - "derivados da 6-azauracila como inibidores da il-5" - Google Patents

"derivados da 6-azauracila como inibidores da il-5"

Info

Publication number
BR9811499A
BR9811499A BR9811499-9A BR9811499A BR9811499A BR 9811499 A BR9811499 A BR 9811499A BR 9811499 A BR9811499 A BR 9811499A BR 9811499 A BR9811499 A BR 9811499A
Authority
BR
Brazil
Prior art keywords
alkyl
aryl
amino
alkyloxy
mono
Prior art date
Application number
BR9811499-9A
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Gustaaf Maria Boeckx
Jean Pierre Frans Van Wauwe
Gaston Stanislas Marcell Diels
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR9811499A publication Critical patent/BR9811499A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0461—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DA 6-AZAURACILA COMO INIBIDORES DA IL-5"<D>. A presente invenção refere-se ao uso de compostos de fórmula (I), seus N-óxidos, seus sais de adição farmaceuticamente aceitáveis e suas formas isoméricas estereoquímicas em que p representa 0,1,2 ou 3, q representa 0,1,2,3 ou 4; R¹ representa hidrogênio, C~ 1-6~alquila, mono- ou di(C~ 1-6~alquil)aminoC~ 1-6~alquilóxi, mercapto, C~ 1-6~ alquiltio, C~ 3-7~cicloalquila, arila ou C~ 1-6~alquila substituída por mono- ou di(C~ 1-6~alquil)amino, C~ 1-6~alquiloxi, arila ou Het; R² representa ciano, ou um radical de fórmula -C(=X)-Y-R^ 5^; em que X representa O ou S; Y representa O,S, NR^ 6^ ou uma ligação direta; R^ 5^ representa hidrogênio, C~ 3-7~cicloalquila, arila ou C~ 1-6~alquila opcionalmente substituída, e onde Y é uma ligação direta, R^ 5^ pode ser também halo ou Het; cada um de R³ e R^ 4^ independentemente representam halo, haloC~ 1-6~alquila, C~ 1-6~alquila, hidroxi, C~ 1-6~alquiloxi, C~ 1-6~alquilcarboniloxi, mercapto, C~ 1-6~alquiltio, C~ 1-6~alquilsulfonila, C~ 1-6~alquilsulfinila, haloC~ 1-6~alquilsulfonila, arila, ciano, nitro, amino, mono- e di(C~ 1-6~alquil)amino ou (C~ 1-6~alquilcarbonil)amino; arila representa fenila, ou fenila substituída; e Het representa um heterociclo opcionalmente substituído; na produção de um medicamento útil no tratamento de doenças inflamatórias dependentes de eosinófilos. A invenção refere-se também a novos compostos, suas preparações e composições contendo os mesmos.
BR9811499-9A 1997-07-10 1998-07-02 "derivados da 6-azauracila como inibidores da il-5" BR9811499A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202117 1997-07-10
PCT/EP1998/004192 WO1999002504A1 (en) 1997-07-10 1998-07-02 6-azauracil derivatives as il-5 inhibitors

Publications (1)

Publication Number Publication Date
BR9811499A true BR9811499A (pt) 2000-09-19

Family

ID=8228530

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811499-9A BR9811499A (pt) 1997-07-10 1998-07-02 "derivados da 6-azauracila como inibidores da il-5"

Country Status (20)

Country Link
US (2) US6743792B2 (pt)
EP (1) EP1003729A1 (pt)
JP (1) JP2002508001A (pt)
KR (1) KR20010012614A (pt)
CN (1) CN1261881A (pt)
AU (1) AU756637B2 (pt)
BR (1) BR9811499A (pt)
CA (1) CA2294533A1 (pt)
EE (1) EE9900585A (pt)
HR (1) HRP990333A2 (pt)
HU (1) HUP0002826A3 (pt)
ID (1) ID24224A (pt)
IL (1) IL133915A0 (pt)
NO (1) NO20000094L (pt)
NZ (1) NZ501627A (pt)
PL (1) PL337875A1 (pt)
SK (1) SK180999A3 (pt)
TR (1) TR199903249T2 (pt)
WO (1) WO1999002504A1 (pt)
ZA (1) ZA986095B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987265A1 (en) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
CA2352275C (en) * 1998-11-23 2008-11-18 Janssen Pharmaceutica N.V. Il-5 inhibiting 6-azauracil derivatives
IL143766A (en) * 1998-12-18 2005-11-20 Janssen Pharmaceutica Nv Il-5 inhibiting 6-azauracil derivatives
WO2001010866A1 (en) * 1999-08-06 2001-02-15 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
US8073380B2 (en) * 2005-12-30 2011-12-06 Nokia Corporation Media content delivery and recording over broadcast network

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883527A (en) 1973-10-19 1975-05-13 Pfizer Process for preparation of 2-aryl-1,3,4-triazine-3,5(2H,4H)-diones
US4631278A (en) * 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
DE4120138A1 (de) * 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
EP0476439A1 (de) * 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
TW263495B (pt) * 1992-12-23 1995-11-21 Celltech Ltd
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
TW332201B (en) * 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
EP0737672B1 (en) * 1995-04-14 2001-10-04 Takeda Schering-Plough Animal Health K.K. Method of producing triazine derivatives

Also Published As

Publication number Publication date
HUP0002826A3 (en) 2003-01-28
NO20000094D0 (no) 2000-01-07
US6743792B2 (en) 2004-06-01
NO20000094L (no) 2000-03-08
US6951857B2 (en) 2005-10-04
WO1999002504A1 (en) 1999-01-21
PL337875A1 (en) 2000-09-11
AU756637B2 (en) 2003-01-16
JP2002508001A (ja) 2002-03-12
HRP990333A2 (en) 2000-04-30
ID24224A (id) 2000-07-13
TR199903249T2 (xx) 2000-09-21
ZA986095B (en) 2000-01-10
AU8441398A (en) 1999-02-08
HUP0002826A2 (hu) 2001-04-28
CN1261881A (zh) 2000-08-02
EE9900585A (et) 2000-08-15
CA2294533A1 (en) 1999-01-21
US20030220331A1 (en) 2003-11-27
EP1003729A1 (en) 2000-05-31
SK180999A3 (en) 2000-10-09
US20020042416A1 (en) 2002-04-11
NZ501627A (en) 2002-02-01
IL133915A0 (en) 2001-04-30
KR20010012614A (ko) 2001-02-15

Similar Documents

Publication Publication Date Title
BR0002515A (pt) Derivados de 4-arilpiperidina para o tratamento do prurido
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
BR0010476A (pt) Compostos derivados do 4,5,6,7-tetrahidroindazol e seu uso como agentes antitumorais
BR0002518A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
AR049126A1 (es) Derivados de 5, 6, 7, 8 - tetrahidroimidazo[1,5a]piridina con actividad inhibitoria de la aldosterona sintasa, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento del hiperaldosterismo y del sindrome de cushing.
AR034448A1 (es) Uso de derivados de nucleosidos, dichos derivados de nucleosidos para dicho uso, composiciones farmaceuticas que los comprenden y uso de dichas composiciones
BR0213790A (pt) Derivados de aminobenzamida como inibidores de glicogênio sintase cinase 3beta
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
BRPI0606817A2 (pt) derivados de piridazina e seu uso como agentes terapêuticos
AR050045A1 (es) Derivados de pirrolo[3,4-c]pirazol activos como inhibidores de quinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden
BR0308146A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
BR0213791A (pt) Derivados de amida como inibidores de glicogênio sintase quinase 3-beta
DK1104760T3 (da) Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
BR9916282A (pt) Composto, uso de um um composto e método de tratamento
BR9812095A (pt) Compostos de indol como inibidores de cox-2
BR0004786A (pt) Compostos farmaceuticamente ativos
BRPI0518231A2 (pt) derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica
EA201190119A1 (ru) ПРОИЗВОДНЫЕ ТРИАЗОЛОПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ МАР-КИНАЗЫ p38
BR9813124A (pt) Compostos indol 2,3-substituìdos como inibidores cox-2
NZ505970A (en) Benzothiadiazoles and derivatives and their use for diseases induced by corticotropine releasing factor (CRF)
BR0215016A (pt) Piridoquinoxalinas antivirìcas
BR0008321A (pt) Secretagogos de hormÈnio de crescimento
PT1157998E (pt) Compostos heterociclicos seus intermediarios e inibidores da elastase
BR9811678A (pt) Derivados de 6-azauracila de inibição de il-5
AR038824A1 (es) Composiciones de medicamentos que, junto a agentes colinergicos, contienen compuestos heterociclicos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.